Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 05, 2014 Filed Feb 7, 2014 21:08 UTC |
SMITH IAN FEVP & CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 68,000 | $0.00 Strike: $77.31 | $0.00 |
DisclosureSEC source: 0001209191-14-008360 · doc4.xml · derivative · entry 3 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,000 Underlying: Common Stock · 68,000 shares Expires 2024-02-04 F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/05/2014. Read SEC document |
| February 05, 2014 Filed Feb 7, 2014 21:08 UTC |
SMITH IAN FEVP & CFO
|
GrantCommon Stock | 20,700 | $0.01 | $207.00 |
DisclosureSEC source: 0001209191-14-008360 · doc4.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,868 F1 · shares: Stock grant under 2006 Stock and Option Plan, vesting on 2/5/2018, subject to (i) acceleration of 50% of shares upon (a) reaching a specified net product sales level over a one-year period for a combination regimen that includes ivacaftor and a CFTR corrector or (b) dosing of the first patient in the first clinical trial to evaluate a second-generation CFTR corrector compound and (ii) acceleration of 50% of shares upon (a) dosing of the first patient in a pivotal trial for a regimen including VX-661 or a specified cancer compound or (b) reaching a specified net product sales level over a one-year period for all our products. Read SEC document |
| January 22, 2014 Filed Jan 23, 2014 21:16 UTC |
SACHS BRUCE IDirector
|
SaleCommon Stock | 400 | $86.91 | $34,764.00 |
DisclosureSEC source: 0001209191-14-004558 · doc4.xml · nonDerivative · entry 4 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,210 F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $86.91 (range $86.53 to $87.43). Read SEC document |
| January 22, 2014 Filed Jan 23, 2014 21:16 UTC |
SACHS BRUCE IDirector
|
SaleCommon Stock | 1,500 | $85.87 | $128,805.00 |
DisclosureSEC source: 0001209191-14-004558 · doc4.xml · nonDerivative · entry 3 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,610 F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $85.87 (range $85.50 to $86.47). Read SEC document |
| January 22, 2014 Filed Jan 23, 2014 21:16 UTC |
SACHS BRUCE IDirector
|
SaleCommon Stock | 600 | $84.90 | $50,940.00 |
DisclosureSEC source: 0001209191-14-004558 · doc4.xml · nonDerivative · entry 2 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,110 F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $84.90 (range $84.47 to $85.45). Read SEC document |
| January 22, 2014 Filed Jan 23, 2014 21:16 UTC |
SACHS BRUCE IDirector
|
SaleCommon Stock | 5,800 | $83.89 | $486,562.00 |
DisclosureSEC source: 0001209191-14-004558 · doc4.xml · nonDerivative · entry 1 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,710 F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $83.89 (range $83.46 to $84.37). F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| January 21, 2014 Filed Jan 23, 2014 21:15 UTC |
Pace Megan ESVP, Corp. Communications
|
SaleCommon Stock | 1,250 | $85.00 | $106,250.00 |
DisclosureSEC source: 0001209191-14-004556 · doc4.xml · nonDerivative · entry 1 Pace Megan E · CIK 0001554979 · SVP, Corp. Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,100 F1 · kind: Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1. Read SEC document |
| January 16, 2014 Filed Jan 17, 2014 21:17 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Exercise / conversionStock Option · Derivative | 45,000 | $0.00 Strike: $29.98 | $0.00 |
DisclosureSEC source: 0001209191-14-003733 · doc4.xml · derivative · entry 4 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,108 Underlying: Common Stock · 45,000 shares Expires 2021-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 12/14/2011. Read SEC document |
| January 16, 2014 Filed Jan 17, 2014 21:17 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 45,000 | $80.00 | $3,600,000.00 |
DisclosureSEC source: 0001209191-14-003733 · doc4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,925 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. Read SEC document |
| January 16, 2014 Filed Jan 17, 2014 21:17 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Exercise / conversionCommon Stock | 45,000 | $29.98 | $1,349,100.00 |
DisclosureSEC source: 0001209191-14-003733 · doc4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2014 Filed Jan 17, 2014 21:16 UTC |
MUELLER PETEREVP, Global R&D, CSO
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $28.84 | $0.00 |
DisclosureSEC source: 0001209191-14-003731 · doc4.xml · derivative · entry 5 MUELLER PETER · CIK 0001256126 · EVP, Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,750 Underlying: Common Stock · 7,500 shares Expires 2017-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| January 15, 2014 Filed Jan 17, 2014 21:16 UTC |
MUELLER PETEREVP, Global R&D, CSO
|
SaleCommon Stock | 7,500 | $78.67 | $590,025.00 |
DisclosureSEC source: 0001209191-14-003731 · doc4.xml · nonDerivative · entry 2 MUELLER PETER · CIK 0001256126 · EVP, Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,500 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $78.67 (range $78.29 to $79.05). F3 · price: Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| January 15, 2014 Filed Jan 17, 2014 21:16 UTC |
MUELLER PETEREVP, Global R&D, CSO
|
Exercise / conversionCommon Stock | 7,500 | $28.84 | $216,300.00 |
DisclosureSEC source: 0001209191-14-003731 · doc4.xml · nonDerivative · entry 1 MUELLER PETER · CIK 0001256126 · EVP, Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2014 Filed Jan 8, 2014 21:19 UTC |
Pace Megan ESVP, Corp. Communications
|
SaleCommon Stock | 838 | $75.00 | $62,850.00 |
DisclosureSEC source: 0001209191-14-002375 · doc4.xml · nonDerivative · entry 1 Pace Megan E · CIK 0001554979 · SVP, Corp. Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,350 F1 · kind: Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1. Read SEC document |
| December 23, 2013 Filed Dec 26, 2013 21:12 UTC |
SACHS BRUCE IDirector
|
SaleCommon Stock | 1,200 | $73.45 | $88,140.00 |
DisclosureSEC source: 0001209191-13-058659 · doc4.xml · nonDerivative · entry 2 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,510 F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $73.45 (range $73.33 to $73.63). Read SEC document |
| December 23, 2013 Filed Dec 26, 2013 21:12 UTC |
SACHS BRUCE IDirector
|
SaleCommon Stock | 7,100 | $72.95 | $517,945.00 |
DisclosureSEC source: 0001209191-13-058659 · doc4.xml · nonDerivative · entry 1 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,710 F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $72.95 (range $72.33 to $73.30). F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| December 16, 2013 Filed Dec 17, 2013 21:21 UTC |
MUELLER PETEREVP, Global R&D, CSO
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $28.84 | $0.00 |
DisclosureSEC source: 0001209191-13-057361 · doc4.xml · derivative · entry 6 MUELLER PETER · CIK 0001256126 · EVP, Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,250 Underlying: Common Stock · 4,500 shares Expires 2017-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| December 16, 2013 Filed Dec 17, 2013 21:21 UTC |
MUELLER PETEREVP, Global R&D, CSO
|
SaleCommon Stock | 2,100 | $65.42 | $137,382.00 |
DisclosureSEC source: 0001209191-13-057361 · doc4.xml · nonDerivative · entry 3 MUELLER PETER · CIK 0001256126 · EVP, Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,500 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $65.42 (range $64.95 to $66.46). Read SEC document |
| December 16, 2013 Filed Dec 17, 2013 21:21 UTC |
MUELLER PETEREVP, Global R&D, CSO
|
SaleCommon Stock | 5,400 | $64.40 | $347,760.00 |
DisclosureSEC source: 0001209191-13-057361 · doc4.xml · nonDerivative · entry 2 MUELLER PETER · CIK 0001256126 · EVP, Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,600 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $64.40 (range $63.94 to $64.83). F3 · price: Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| December 16, 2013 Filed Dec 17, 2013 21:21 UTC |
MUELLER PETEREVP, Global R&D, CSO
|
Exercise / conversionCommon Stock | 7,500 | $28.84 | $216,300.00 |
DisclosureSEC source: 0001209191-13-057361 · doc4.xml · nonDerivative · entry 1 MUELLER PETER · CIK 0001256126 · EVP, Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2013 Filed Dec 12, 2013 22:48 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 3,021 | $65.47 | $197,784.87 |
DisclosureSEC source: 0001209191-13-056694 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,718 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $65.47 (range $65.06 to $65.92). F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| December 12, 2013 Filed Dec 12, 2013 22:49 UTC |
Connolly ThomasSVP, Human Resources
|
SaleCommon Stock | 480 | $65.50 | $31,440.00 |
DisclosureSEC source: 0001209191-13-056695 · doc4.xml · nonDerivative · entry 1 Connolly Thomas · CIK 0001453943 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,772 F1 · kind: Transaction made pursuant to Mr. Connolly's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $65.50 (range $65.16 to $65.72). F3 · price: Mr. Connolly undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| December 12, 2013 Filed Dec 12, 2013 22:49 UTC |
Horton Kenneth LEVP & Chief Legal Officer
|
SaleCommon Stock | 4,532 | $65.46 | $296,664.72 |
DisclosureSEC source: 0001209191-13-056696 · doc4.xml · nonDerivative · entry 1 Horton Kenneth L · CIK 0001552047 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,624 F1 · kind: Transaction made pursuant to Mr. Horton's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $65.46 (range $65.05 to $65.91). F3 · price: Mr. Horton undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| December 12, 2013 Filed Dec 12, 2013 22:50 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 9,834 | $65.48 | $643,930.32 |
DisclosureSEC source: 0001209191-13-056697 · doc4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,925 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $65.48 (range $65.05 to $65.92). F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| December 12, 2013 Filed Dec 12, 2013 22:51 UTC |
MUELLER PETEREVP, Global R&D, CSO
|
SaleCommon Stock | 2,900 | $65.48 | $189,892.00 |
DisclosureSEC source: 0001209191-13-056698 · doc4.xml · nonDerivative · entry 1 MUELLER PETER · CIK 0001256126 · EVP, Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,500 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $65.48 (range $65.06 to $65.91). F3 · price: Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| December 12, 2013 Filed Dec 12, 2013 22:51 UTC |
Pace Megan ESVP, Corp. Communications
|
SaleCommon Stock | 5,083 | $65.48 | $332,834.84 |
DisclosureSEC source: 0001209191-13-056699 · doc4.xml · nonDerivative · entry 1 Pace Megan E · CIK 0001554979 · SVP, Corp. Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,188 F1 · kind: Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $65.48 (range $65.05 to $65.91). F3 · price: Ms. Pace undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| December 12, 2013 Filed Dec 12, 2013 22:52 UTC |
Sachdev AmitSVP, Global Gov. Strategy
|
SaleCommon Stock | 2,542 | $65.47 | $166,424.74 |
DisclosureSEC source: 0001209191-13-056701 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · SVP, Global Gov. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,561 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $65.47 (range $65.06 to $65.93). F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| December 04, 2013 Filed Dec 5, 2013 21:25 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,400 | $0.00 Strike: $9.07 | $0.00 |
DisclosureSEC source: 0001209191-13-055496 · doc4.xml · derivative · entry 5 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,400 shares Expires 2013-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| December 04, 2013 Filed Dec 5, 2013 21:25 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 1,400 | $67.48 | $94,472.00 |
DisclosureSEC source: 0001209191-13-055496 · doc4.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,895 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $67.48 (range $67.35 to $67.52). F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| December 04, 2013 Filed Dec 5, 2013 21:25 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionCommon Stock | 1,400 | $9.07 | $12,698.00 |
DisclosureSEC source: 0001209191-13-055496 · doc4.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2013 Filed Dec 5, 2013 21:26 UTC |
Connolly ThomasSVP, Human Resources
|
Exercise / conversionStock Option (right to buy) · Derivative | 937 | $0.00 Strike: $53.74 | $0.00 |
DisclosureSEC source: 0001209191-13-055498 · doc4.xml · derivative · entry 4 Connolly Thomas · CIK 0001453943 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,313 Underlying: Common Stock · 937 shares Expires 2022-09-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests in 16 quarterly installments from 09/04/2012. Read SEC document |
| December 04, 2013 Filed Dec 5, 2013 21:26 UTC |
Connolly ThomasSVP, Human Resources
|
SaleCommon Stock | 937 | $67.38 | $63,135.06 |
DisclosureSEC source: 0001209191-13-055498 · doc4.xml · nonDerivative · entry 2 Connolly Thomas · CIK 0001453943 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,252 F1 · kind: Transaction made pursuant to Mr. Connolly's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $67.38 (range $67.00 to $67.72). F3 · price: Mr. Connolly undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| December 04, 2013 Filed Dec 5, 2013 21:26 UTC |
Connolly ThomasSVP, Human Resources
|
Exercise / conversionCommon Stock | 937 | $53.74 | $50,354.38 |
DisclosureSEC source: 0001209191-13-055498 · doc4.xml · nonDerivative · entry 1 Connolly Thomas · CIK 0001453943 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2013 Filed Nov 26, 2013 21:18 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,400 | $0.00 Strike: $9.07 | $0.00 |
DisclosureSEC source: 0001209191-13-054132 · doc4.xml · derivative · entry 5 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 Underlying: Common Stock · 1,400 shares Expires 2013-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| November 25, 2013 Filed Nov 26, 2013 21:18 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 1,400 | $66.89 | $93,646.00 |
DisclosureSEC source: 0001209191-13-054132 · doc4.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,895 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $66.89 (range $66.82 to $67.00). F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 25, 2013 Filed Nov 26, 2013 21:18 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionCommon Stock | 1,400 | $9.07 | $12,698.00 |
DisclosureSEC source: 0001209191-13-054132 · doc4.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2013 Filed Nov 21, 2013 21:54 UTC |
SACHS BRUCE IDirector
|
SaleCommon Stock | 200 | $67.15 | $13,430.00 |
DisclosureSEC source: 0001209191-13-053549 · doc4.xml · nonDerivative · entry 5 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,810 F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $67.15 (range $67.14 to $67.16). Read SEC document |
| November 20, 2013 Filed Nov 21, 2013 21:54 UTC |
SACHS BRUCE IDirector
|
SaleCommon Stock | 1,700 | $66.25 | $112,625.00 |
DisclosureSEC source: 0001209191-13-053549 · doc4.xml · nonDerivative · entry 4 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,010 F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $66.25 (range $66.00 to $66.80). Read SEC document |
| November 20, 2013 Filed Nov 21, 2013 21:54 UTC |
SACHS BRUCE IDirector
|
SaleCommon Stock | 4,900 | $65.35 | $320,215.00 |
DisclosureSEC source: 0001209191-13-053549 · doc4.xml · nonDerivative · entry 3 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,710 F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $65.35 (range $64.92 to $65.86). Read SEC document |
| November 20, 2013 Filed Nov 21, 2013 21:54 UTC |
SACHS BRUCE IDirector
|
SaleCommon Stock | 800 | $64.21 | $51,368.00 |
DisclosureSEC source: 0001209191-13-053549 · doc4.xml · nonDerivative · entry 2 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,610 F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $64.21 (range $63.82 to $64.62). Read SEC document |
| November 20, 2013 Filed Nov 21, 2013 21:54 UTC |
SACHS BRUCE IDirector
|
SaleCommon Stock | 700 | $63.10 | $44,170.00 |
DisclosureSEC source: 0001209191-13-053549 · doc4.xml · nonDerivative · entry 1 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,410 F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $63.10 (range $62.80 to $63.33). F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 19, 2013 Filed Nov 21, 2013 21:53 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,400 | $0.00 Strike: $9.07 | $0.00 |
DisclosureSEC source: 0001209191-13-053548 · doc4.xml · derivative · entry 5 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,800 Underlying: Common Stock · 1,400 shares Expires 2013-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| November 19, 2013 Filed Nov 21, 2013 21:53 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 1,400 | $62.31 | $87,234.00 |
DisclosureSEC source: 0001209191-13-053548 · doc4.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,895 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $62.31 (range $61.88 to $62.52). F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 19, 2013 Filed Nov 21, 2013 21:53 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionCommon Stock | 1,400 | $9.07 | $12,698.00 |
DisclosureSEC source: 0001209191-13-053548 · doc4.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2013 Filed Nov 19, 2013 21:18 UTC |
MUELLER PETEREVP, Global R&D, CSO
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,500 | $0.00 Strike: $28.84 | $0.00 |
DisclosureSEC source: 0001209191-13-053081 · doc4.xml · derivative · entry 9 MUELLER PETER · CIK 0001256126 · EVP, Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,750 Underlying: Common Stock · 4,500 shares Expires 2017-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| November 15, 2013 Filed Nov 19, 2013 21:18 UTC |
MUELLER PETEREVP, Global R&D, CSO
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $18.93 | $0.00 |
DisclosureSEC source: 0001209191-13-053081 · doc4.xml · derivative · entry 8 MUELLER PETER · CIK 0001256126 · EVP, Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2018-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| November 15, 2013 Filed Nov 19, 2013 21:18 UTC |
MUELLER PETEREVP, Global R&D, CSO
|
SaleCommon Stock | 2,200 | $63.12 | $138,864.00 |
DisclosureSEC source: 0001209191-13-053081 · doc4.xml · nonDerivative · entry 5 MUELLER PETER · CIK 0001256126 · EVP, Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,400 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $63.12 (range $63.02 to $63.26). Read SEC document |
| November 15, 2013 Filed Nov 19, 2013 21:18 UTC |
MUELLER PETEREVP, Global R&D, CSO
|
SaleCommon Stock | 4,200 | $62.62 | $263,004.00 |
DisclosureSEC source: 0001209191-13-053081 · doc4.xml · nonDerivative · entry 4 MUELLER PETER · CIK 0001256126 · EVP, Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,600 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $62.62 (range $62.00 to $62.98). Read SEC document |
| November 15, 2013 Filed Nov 19, 2013 21:18 UTC |
MUELLER PETEREVP, Global R&D, CSO
|
SaleCommon Stock | 1,100 | $61.58 | $67,738.00 |
DisclosureSEC source: 0001209191-13-053081 · doc4.xml · nonDerivative · entry 3 MUELLER PETER · CIK 0001256126 · EVP, Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,800 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $61.58 (range $61.00 to $61.97). F3 · price: Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 15, 2013 Filed Nov 19, 2013 21:18 UTC |
MUELLER PETEREVP, Global R&D, CSO
|
Exercise / conversionCommon Stock | 3,000 | $18.93 | $56,790.00 |
DisclosureSEC source: 0001209191-13-053081 · doc4.xml · nonDerivative · entry 2 MUELLER PETER · CIK 0001256126 · EVP, Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.